AUPP968699A0 - Therapeutic compositions and method for their preparation - Google Patents

Therapeutic compositions and method for their preparation

Info

Publication number
AUPP968699A0
AUPP968699A0 AUPP9686A AUPP968699A AUPP968699A0 AU PP968699 A0 AUPP968699 A0 AU PP968699A0 AU PP9686 A AUPP9686 A AU PP9686A AU PP968699 A AUPP968699 A AU PP968699A AU PP968699 A0 AUPP968699 A0 AU PP968699A0
Authority
AU
Australia
Prior art keywords
preparation
therapeutic compositions
therapeutic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP9686A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CURA NOMINEES Pty Ltd
Original Assignee
CURA NOMINEES Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CURA NOMINEES Pty Ltd filed Critical CURA NOMINEES Pty Ltd
Priority to AUPP9686A priority Critical patent/AUPP968699A0/en
Publication of AUPP968699A0 publication Critical patent/AUPP968699A0/en
Priority to EP00913972A priority patent/EP1181022A4/en
Priority to PCT/AU2000/000300 priority patent/WO2000061153A1/en
Priority to AU35454/00A priority patent/AU779512B2/en
Priority to CA002369272A priority patent/CA2369272A1/en
Priority to US10/752,095 priority patent/US20040220115A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AUPP9686A 1999-04-09 1999-04-09 Therapeutic compositions and method for their preparation Abandoned AUPP968699A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPP9686A AUPP968699A0 (en) 1999-04-09 1999-04-09 Therapeutic compositions and method for their preparation
EP00913972A EP1181022A4 (en) 1999-04-09 2000-04-10 Medicinal compositions and their method of preparation
PCT/AU2000/000300 WO2000061153A1 (en) 1999-04-09 2000-04-10 Medicinal compositions and their method of preparation
AU35454/00A AU779512B2 (en) 1999-04-09 2000-04-10 Medicinal compositions and their method of preparation
CA002369272A CA2369272A1 (en) 1999-04-09 2000-04-10 Medicinal compositions and their method of preparation
US10/752,095 US20040220115A1 (en) 1999-04-09 2004-01-07 Medicinal compositions and their method of preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP9686A AUPP968699A0 (en) 1999-04-09 1999-04-09 Therapeutic compositions and method for their preparation

Publications (1)

Publication Number Publication Date
AUPP968699A0 true AUPP968699A0 (en) 1999-05-06

Family

ID=3813885

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP9686A Abandoned AUPP968699A0 (en) 1999-04-09 1999-04-09 Therapeutic compositions and method for their preparation

Country Status (4)

Country Link
EP (1) EP1181022A4 (en)
AU (1) AUPP968699A0 (en)
CA (1) CA2369272A1 (en)
WO (1) WO2000061153A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
WO2003029269A1 (en) * 2001-09-28 2003-04-10 Glycomed Sciences Limited Solvent extraction process
WO2003030915A1 (en) * 2001-10-09 2003-04-17 Glycomed Sciences Limited Use of solamargine for treating skin tumors
WO2003030884A2 (en) * 2001-10-09 2003-04-17 Glycomed Sciences Limited Use of solasonine for the treatment of skin tumors
US6984725B2 (en) 2002-06-28 2006-01-10 Solbec Pharmaceuticals Ltd. Method for the separation of triglycoalkaloids
AUPS326302A0 (en) * 2002-06-28 2002-07-18 Solbec Pharmaceuticals Limited Method for the separation of solamargine and solasonine
AU2003900194A0 (en) * 2003-01-15 2003-01-30 Solbec Pharmaceuticals Limited Methods of modulating il-6
TWI300352B (en) * 2003-06-05 2008-09-01 G & E Herbal Biotechnology Co Ltd Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
DK1508334T3 (en) * 2003-08-22 2010-06-21 G & E Herbal Biotechnology Co Water-soluble plant extract from solanum, its preparation and pharmaceutical composition containing the water-soluble extract
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
EP1858526A1 (en) * 2005-03-02 2007-11-28 Solbec Pharmaceuticals Limited Glycoalkaloid and tlr agonist combinations and various uses thereof
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
EP1928250A4 (en) * 2005-09-27 2010-04-28 Univ Kentucky Res Found Berry preparations and extracts
TWI414304B (en) * 2011-05-04 2013-11-11 G & E Herbal Biotechnology Co Ltd Treatment of wart with a water soluble extract from plant of solanum genus
TWI476012B (en) * 2011-05-12 2015-03-11 G & E Herbal Biotechnology Co Ltd Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water soluble extract from plant of solanum genus
CA2838275C (en) * 2011-06-06 2021-08-10 University Of Iowa Research Foundation Methods for inhibiting muscle atrophy
CN105192820A (en) * 2015-08-20 2015-12-30 泰山医学院 Blood-fat-reducing cordyceps militaris polysaccharide beverage and preparing method thereof
CN108883123B (en) * 2016-03-03 2022-04-19 B·E·查姆 Glycoalkaloid combinations and various uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU540812B2 (en) * 1979-05-02 1984-12-06 Aruba Qld Pty. Ltd. Steroid alkaloids
ATE188036T1 (en) * 1990-01-18 2000-01-15 Cura Nominees Pty Ltd GLYCOALKALOIDS

Also Published As

Publication number Publication date
EP1181022A4 (en) 2004-02-11
CA2369272A1 (en) 2000-10-19
EP1181022A1 (en) 2002-02-27
WO2000061153A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
AUPQ419099A0 (en) Novel compositions and methods
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2091499A (en) Permeable compositions and methods for their preparation
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU3192700A (en) Medicinal compositions
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU2005300A (en) Medicinal compositions
AU3864900A (en) Compositions and methods for their preparation from (lepidium)
AU5565099A (en) Pharmaceutical compositions and methods for use
AU1887401A (en) Medicinal composition
AU3913800A (en) Novel antioxidant formulations and methods for using them
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU6056500A (en) Process and composition for temporarily suppressing pain
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU3926000A (en) Methods and compositions for drug delivery
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU4709900A (en) Hmx compositions and processes for their preparation
AU2880699A (en) Pharmaceutical compositions and methods for use
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU1567301A (en) Tablets comprising micro-organisms and method for preparation of the tablets
AU3321100A (en) Method and pharmaceutical composition for wound healing
AU2136500A (en) Preparation for dental treatment
AU5931300A (en) Ringene compositions and methods for use thereof

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 3545400

Country of ref document: AU